Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

(2014) P. Valent et al.   ANNALS OF ONCOLOGY

CD52 is a molecular target in advanced systemic mastocytosis

(2014) Gregor Hoermann et al.   FASEB JOURNAL

ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases

(2014) Gandhi Damaj et al.   PLoS One

Comprehensive mutational profiling in advanced systemic mastocytosis

(2013) J. Schwaab et al.   BLOOD

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

(2013) José M Morgado et al.   HISTOPATHOLOGY

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

(2013) Cristina Teodosio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mast cell leukemia

(2012) S. Georgin-Lavialle et al.   BLOOD

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

(2012) Peter Valent et al.   WIENER KLINISCHE WOCHENSCHRIFT

Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536

(2011) B. Peter et al.   HAEMATOLOGICA

Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms

(2011) Peter Valent et al.   LEUKEMIA & LYMPHOMA

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

(2010) Y. Yang et al.   BLOOD

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

(2010) Karl Sotlar et al.   MODERN PATHOLOGY

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives

(2010) Michel Arock et al.   Expert Review of Hematology

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine

(2009) Ken H. Lim et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies

(2009) A. Pardanani et al.   BLOOD

Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations

(2009) Christine Bodemer et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mast cells and mastocytosis

(2008) D. D. Metcalfe   BLOOD

Advanced mast cell disease: an Italian Hematological Multicenter experience

(2008) Livio Pagano et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY